drugset / Trial / NCT04763265

Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines

NCT04763265 ↗

Phase 2 Completed 208 enrolled Croma-Pharma GmbH Hugel · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the study is to provide preliminary comparative data on BoNT/A-DP versus Botox Cosmetic. Subsequently the sample size is primarily based on clinical judgement and practical considerations.

Timeline

Start
2020-06-24
Primary completion
2020-11-05
Completion
2021-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator BoNT/A-DP Unknown 20 iu Intramuscular
Comparator Botox Cosmetics Unknown 20 iu Intramuscular

Indications

No indication recorded.